Mucinex Maximum Strength Fast-Max Cold & Flu and Nightshift, All-in-One Multi Symptom Relief Liquid, 6 Fl Oz - 2 Count (Pack of 1)

Maximum Strength Mucinex Fast-Max Cold & Flu and Mucinex NightShift Maximum Strength Severe Cold & Flu Day Night Combo pack is a Multi-Symptom Relief medicine and All-in-One solution for Cold & Flu symptoms. Fast-Max Cold & Flu liquid help reduce Fever, relieves Cough, Nasal congestion, Body pain, Sore Throat, Chest Congestion, Sinus Pressure & Congestion, Headache. NightShift liquid reduce Fever, relieves Cough, Nasal Congestion, Body pain, Sore Throat, Itchy Throat, Runny Nose, Sneezing and Headache. Mucinex is the #1 Cough & Cold Brand Doctors Trust* and #1 Pharmacist Recommended Brand† as well. This product contains two 6 FL OZ bottles. It can be consumed by Adults and Children aged 12 years and above. MULTI-SYMPTOMS ALLEVIATED DAY TIME SYMPTOMS ALLEVIATED: Mucinex Fast-Max Cold & Flu is All-in-One solution to relieve 9 symptoms - Fever, Cough, Nasal Congestion, Body pain, Sore Throat, Chest congestion, Sinus pressure, Sinus congestion and Headache NIGHT TIME SYMPTOMS ALLEVIATED: Mucinex Night Shift Severe Cold & Flu is All-in-One solution to relieve 9 symptoms - Fever, Cough, Nasal Congestion, Body pain, Sore Throat, Itchy Throat, Runny nose, Sneezing and Headache KEY INGREDIENTS FAST-MAX COLD & FLU ACTIVE INGREDIENTS (DAY): Contains Acetaminophen - pain reliever and fever reducer; Dextromethorphan HBr - cough suppressant; Guaifenesin - expectorant/thins and loosens mucus; Phenylephrine HCI - nasal decongestant NIGHTSHIFT SEVERE COLD & FLU ACTIVE INGREDIENTS (NIGHT): Contains Acetaminophen - pain reliever and fever reducer; Dextromethorphan HBr - cough suppressant; Phenylephrine HCI - nasal decongestant; Triprolidine HCl - Antihistamine to alleviate sneezing, runny and itchy nose and watery eyes Do not take Mucinex Fast-Max Cold & Flu and Mucinex Nightshift Severe Cold & Flu at the same time. Always wait at least 4 hours before taking another dose of Mucinex liquid. TAKE ONLY AS DIRECTED. *IQVIA using ProVoice Survey, December 2022 †U.S. News & World Report/Pharmacy Times 2023-2024